Luton, Bedfordshire, United Kingdom, Nov. 15, 2024 (GLOBE NEWSWIRE) -- The global cardiac device market is experiencing tremendous growth. This is driven by the increasing prevalence of chronic heart disease. This increase in heart conditions is driving the use of high-tech devices for diagnostic and surgical purposes. In addition, the price drop of critical cardiac medical equipment such as coronary stents is decreasing. It is helping to increase market expansion. Particularly in emerging markets like India, Harvard's T.H. Chan School of Public Health found that the number of heart procedures in Maharashtra increased 43% as the price of coronary stents dropped. It emphasizes the positive impact of affordable medical devices on patients' treatment choices.
Access PDF Sample Report (Including Graphs, Charts & Figures) @
https://exactitudeconsultancy.com/reports/24647/cardiovascular-devices-market/#request-a-sample
This growth trend will continue. with key market players increasing their R&D efforts to develop innovative products designed to improve outcomes for cardiovascular patients. The increasing incidence of cardiovascular disease across the world is also fueling the expansion of this market. As a result, the cardiology devices market is poised for strong growth throughout the forecast period. Although the spread of COVID-19 will have a negative impact on the market. This is especially true because elective heart surgery procedures have been postponed and hospital admissions have decreased. But the market is continuing to recover. The pandemic has delayed non-urgent procedures, such as percutaneous coronary intervention (PCI) for stable ischemic heart disease. This is because health care resources have been redirected to managing COVID-19. But demand for cardiac equipment is increasing. Innovative products...from the beginning have helped The market returns to its pre-epidemic growth trajectory.
- Technological Innovation in Cardiology Devices: Major players in the industry continue to focus on developing cutting-edge diagnostic and therapeutic solutions, such as AI-powered diagnostic tools and advanced stent technologies, to enhance patient outcomes and broaden market adoption.
- Regional Expansion: The demand for cardiology devices is expected to rise significantly in emerging markets, particularly in regions like Asia-Pacific and Latin America, as healthcare infrastructure improves and access to advanced medical technologies increases.
- Government Initiatives: Governments worldwide are increasingly prioritizing healthcare reforms, including the expansion of cardiology services, which is expected to further drive demand for heart disease-related medical devices.
High Demand for Advanced Cardiovascular Devices Drives Market Growth
The growing demand for advanced cardiovascular devices is propelled by an increasing number of patients suffering from chronic heart diseases, many of whom require state-of-the-art diagnostic and therapeutic solutions. This is particularly true for coronary stents and other devices with enhanced safety features. Patients now seek devices that not only provide effective treatment but also minimize the risk of complications, such as infections often associated with bare-metal stents.
Technological advancements have also spurred a demand for devices with remote cardiac monitoring capabilities. These features provide patients with accurate, real-time insights into their heart health, improving overall treatment efficacy and patient convenience. As a result, leading manufacturers in the cardiovascular devices market are prioritizing the development of innovative, feature-rich products. For example, in November 2021, Medtronic launched the Arctic Front Cardiac Cryoablation Catheter System, the first cryoballoon catheter to receive CDSCO approval, designed for treating atrial fibrillation. Similarly, in February 2021, Remo Care Solutions introduced an AI-powered remote cardiac monitoring device, Remo.Cardia, which analyzes patients' vitals in real-time, offering effective monitoring for individuals with cardiovascular conditions.
The growing patient pool, paired with the increasing demand for advanced features, is expected to significantly drive the growth of the cardiovascular devices market in the coming years.
- Technological Advancements and Patient-Centered Features: The rising preference for devices that integrate features like AI, wireless connectivity, and remote monitoring is making these tools indispensable for both healthcare professionals and patients. These devices not only provide real-time data but also enable more tailored and effective treatment plans, which is especially important for individuals in need of continuous monitoring.
- Emerging Markets: The rise of emerging markets, where a greater focus on affordability and accessibility of advanced cardiovascular devices is occurring, is also a significant driver. Increased awareness and healthcare infrastructure improvements in countries such as India, Brazil, and China are contributing to the demand for cost-effective yet advanced cardiovascular technologies.
- Market Recovery Post-COVID-19: While the pandemic temporarily disrupted elective cardiovascular procedures, there is now a rebound in the demand for cardiovascular devices as health systems resume normal operations. The resurgence in heart disease diagnoses and treatments is fueling further growth in this sector.
Increase in Cardiovascular Diseases Prevalence to Drive Global Market Growth
The global cardiovascular devices market is poised for significant growth, largely driven by the rising prevalence of heart diseases. Cardiovascular diseases (CVDs) are among the most costly in terms of healthcare services, and conditions such as coronary artery disease (CAD) and heart failure are becoming increasingly prevalent. Coronary stents, crucial devices used in treating life-threatening conditions such as heart attacks, atrial fibrillation, and blocked arteries, are in high demand as they offer vital treatment for patients with these conditions.
Data from the Centers for Disease Control and Prevention (CDC) highlighted that in 2022, approximately 4.9% of adults in the U.S. were diagnosed with coronary heart disease, and CVDs remain the leading cause of death in the country, accounting for 695,547 deaths in the same year. Globally, the World Health Organization (WHO) estimates that heart diseases are responsible for approximately 17.9 million deaths annually. These alarming statistics emphasize the increasing need for innovative and advanced cardiovascular devices.
Further driving market expansion, the surge in device approvals by regulatory authorities is expected to fuel market growth. Additionally, various public initiatives aimed at expanding access to cardiovascular devices in developing regions are expected to enhance market prospects, particularly in underserved areas.
- Regulatory Approvals and Innovation: The acceleration in approvals for new devices by regulatory bodies like the FDA and European Medicines Agency (EMA) has provided a significant boost to the market. Companies are focusing on research and development to introduce innovative technologies, improving treatment options for patients worldwide.
- Rising Awareness in Developing Markets: Countries in Asia, Africa, and Latin America are seeing an increase in healthcare awareness and infrastructure development, which is contributing to the rising demand for cardiovascular devices. This presents substantial opportunities for manufacturers targeting emerging markets.
- Aging Population: As the global population continues to age, the incidence of chronic heart conditions is expected to rise. This demographic shift further underscores the growing need for cardiovascular devices that can address a wide range of heart diseases.
Report Link Click Here: https://exactitudeconsultancy.com/reports/24647/cardiovascular-devices-market/
Increasing Availability of Efficient Devices to Propel Market Growth
The global cardiovascular devices market is witnessing significant growth, driven by the increasing prevalence of heart diseases and the expanding availability of advanced and cost-effective devices. As healthcare systems in emerging markets such as India, China, and Mexico continue to develop, the demand for these life-saving technologies has surged. With numerous initiatives aimed at improving access to affordable cardiovascular devices in these regions, market growth is set to accelerate in the coming years.
For example, in January 2023, UltraLinQ Healthcare Solutions introduced a new cardiac monitoring product at the Arab Health 2023. This end-to-end system allows specialist clinics and hospitals to offer Holter services remotely, enhancing patient access to care, even in the comfort of their homes. Such innovations are helping bridge healthcare gaps in emerging economies, further driving the adoption of cardiovascular devices.
Increasing Barriers in R&D Activities Could Restrict Market Growth
Despite these positive developments, the cardiovascular devices market faces challenges in terms of research and development (R&D) efforts. The high costs associated with the advancement of innovative devices, compounded by ineffective reimbursement models, have created barriers to progress. For example, countries that impose price caps on essential life-saving devices, such as coronary stents, discourage manufacturers from investing in new product developments. This can slow innovation and the introduction of advanced devices into the market.
Additionally, stringent regulatory policies are also restricting market growth. Devices that do not meet regulatory guidelines cannot be commercialized, resulting in financial losses for manufacturers. Furthermore, product recalls have become more frequent in recent years, tarnishing the reputation of manufacturers. For instance, in 2023, the U.S. FDA announced that Abbott recalled its NC Traveler RX Coronary Dilatation Catheters due to issues with balloon deflation. These challenges underscore the hurdles manufacturers must navigate to ensure the continued growth and innovation of the cardiovascular devices market.
North America to Maintain Dominance in the Cardiovascular Devices Market
North America continues to dominate the global cardiovascular devices market, with the U.S. accounting for a significant share in 2023. This is driven by a combination of factors including the prevalence of cardiovascular diseases, increased healthcare expenditure, and robust access to advanced medical infrastructure. According to the American Heart Association, cardiovascular diseases were responsible for around 18.6 million deaths in the U.S. in 2019, highlighting the significant burden of these diseases. The growing adoption of innovative medical technologies, alongside favorable reimbursement policies and a strong healthcare infrastructure, has led to an increased demand for cardiovascular diagnostic devices and surgical interventions across the region.
Asia Pacific: The Fastest-Growing Market for Cardiovascular Devices
The Asia Pacific (APAC) region is expected to exhibit the fastest growth in the cardiovascular devices market during the forecast period. This growth is driven by factors such as a large population base, rising incidence of cardiovascular diseases, increasing healthcare expenditure, and investments in healthcare infrastructure. According to the World Health Organization, approximately 75% of deaths from cardiovascular diseases occur in low- and middle-income countries, underscoring the region's vulnerability. The increasing accessibility to healthcare services, alongside the rising affordability of medical technologies, is fueling the adoption of cardiovascular devices in these areas. Moreover, the rapidly expanding geriatric population, which is expected to constitute 80% of the global elderly population by 2050, will further drive the demand for cardiovascular devices in the APAC region.
Key Drivers of Cardiovascular Devices Market Growth
The global cardiovascular devices market is experiencing significant growth due to several key factors, most notably the increasing prevalence of chronic cardiovascular diseases worldwide. According to the World Health Organization (WHO), cardiovascular diseases are the leading cause of death globally, accounting for an estimated 17.9 million deaths each year. Key contributors to this rise include unhealthy diets high in salt, increased tobacco use, alcohol consumption, and the growing incidence of obesity and physical inactivity, all of which heighten the risk of cardiovascular conditions.
The demand for early diagnosis is a major factor in driving the market, as early detection of cardiovascular diseases can significantly improve treatment outcomes. In addition, the aging population is contributing to the rise in cardiovascular diseases, as older individuals are more susceptible. The United Nations projects that by 2050, the global geriatric population will reach approximately 2 billion, further increasing the demand for cardiovascular care.
The market is also buoyed by technological advancements, particularly in product innovations. For example, in February 2021, Remo Care Solutions introduced an AI-based remote monitoring device designed to analyze real-time cardiovascular conditions of patients. This integration of artificial intelligence (AI) into cardiovascular devices is enhancing patient care services and helping to reduce mortality rates. Additionally, the rising investments by leading market players in research, development, and clinical trials are expected to open new avenues for growth in the coming years, further accelerating the demand for these critical devices.
Cardiovascular Devices Market Key Players:
- B. Braun Melsungen AG (Melsungen, Germany)
- Medtronic (Dublin, Ireland)
- Abbott (Abbott Park, U.S.)
- Boston Scientific Corporation (Marlborough, U.S.)
- Edwards Lifesciences Corporation (Irvine, U.S.)
- Johnson & Johnson Services, Inc. (New Brunswick, U.S.)
- GENERAL ELECTRIC COMPANY (GE Healthcare) (Chicago, U.S.)
- LivaNova PLC (London, U.K.)
- Siemens Healthcare GmbH (Erlangen, Germany)
- Terumo Cardiovascular Systems Corporation (Tokyo, Japan)
- Medtronic
- LivaNova Plc
- Edwards Lifesciences Corporation
- GE Healthcare
- Siemens Healthcare GmbH
Key Developments
- In 2023, a new ablation technology, pulsed field ablation (PFA), showed promise as a safer and faster alternative to traditional thermal ablation for treating atrial fibrillation (AFib). This technique uses electrical fields to target heart muscle cells without damaging surrounding tissues, offering a potentially more effective treatment for AFib patients.
- Recent studies have confirmed that endovascular thrombectomy, a minimally invasive procedure to remove blood clots from the brain, benefits even patients with large, severe strokes. This development could improve outcomes for patients who previously had limited treatment options.
- In recent trials, advanced imaging technologies have improved the placement of stents in patients with complex coronary lesions. These new techniques help doctors achieve better outcomes for patients with challenging heart conditions, including those with diabetes.
- Zilebesiran, a new drug targeting blood pressure regulation, showed positive results in clinical trials by offering long-lasting blood pressure reductions with a single injection. This medication could potentially become a significant advancement in treating hypertension and related cardiovascular conditions.
- In February 2021, Remo Care Solutions introduced an AI-based remote monitoring device for cardiac patients. This device analyzes cardiovascular conditions in real time, improving management and potentially reducing hospital visits.
Segments Covered in the Report
By Device Type
- Diagnostic & Monitoring
- ECG
- Holter Monitors
- Event Monitors
- Implantable Loop Recorders
- Echocardiogram
- Pet Scan
- MRI
- Cardiac CT
- Doppler Fetal Monitors
- Therapeutic & Surgical Devices
- Pacemakers
- Stents
- Catheters and accessories
- Guidewires
- Cannulae
- Electrosurgical Procedures
- Valves
- Occlusion Devices
- Others
By End User
- Hospitals
- Specialty Clinics
- Others
By Application
- Cardiac Arrhythmia
- Coronary Artery Disease
- Heart Failure
- Others
By Geography
- North America
- U.S.
- Canada
- Europe
- U.K.
- Germany
- France
- Asia Pacific
- China
- India
- Japan
- South Korea
- MEA
- Latin America
- Rest of the World
Get a Sample PDF Brochure: https://exactitudeconsultancy.com/reports/24647/cardiovascular-devices-market/#request-a-sample
Related Reports:
Optical Imaging Market
https://exactitudeconsultancy.com/reports/2375/optical-imaging-market/
The global optical imaging market is expected to grow at more than 15.1% CAGR from 2019 to 2028. It is expected to reach above USD 4.25 billion by 2028 from a little above USD 1.11 billion in 2019.
Denture Market
https://exactitudeconsultancy.com/reports/5020/denture-market/
The global denture market is expected to grow at 6% CAGR from 2022 to 2029. It is expected to reach above USD 3.48 billion by 2029 from USD 2.15 billion in 2020.
Electronic Drug Delivery Systems Market
https://exactitudeconsultancy.com/reports/1262/electronic-drug-delivery-systems-market/
The Global Electronic Drug Delivery Systems Market is expected to grow at 8.1% CAGR from 2019 to 2028. It is expected to reach above USD 14.36 million by 2028 from USD 7.50 million in 2019.
Medical Adhesives Market
https://exactitudeconsultancy.com/reports/3134/medical-adhesives-market/
The medical adhesive market is projected to grow from USD 8.14 billion in 2020 to USD 15.60 billion by 2029, at a CAGR of 7.5% between 2022 and 2029.
Cryogenic Equipment Market
https://exactitudeconsultancy.com/reports/5442/cryogenic-equipment-market/
The global cryogenic equipment market is expected to grow at more than 7.2% CAGR from 2022 to 2029. It is expected to reach above USD 41.5 billion by 2029 from USD 22.19 billion in 2020.
Peripheral Vascular Devices Market
https://exactitudeconsultancy.com/reports/5615/peripheral-vascular-devices-market/
The global peripheral vascular devices market is expected to grow at 6% CAGR from 2022 to 2029. It is expected to reach above USD 17.74 billion by 2029 from USD 10.5 billion in 2020.
Transcatheter Aortic Valve Replacement (TAVR) Market
https://exactitudeconsultancy.com/reports/3811/transcatheter-aortic-valve-replacement-tavr-market/
The global transcatheter aortic valve replacement (TAVR) market is expected to grow at 22% CAGR from 2022 to 2029. It is expected to reach above USD 26 billion by 2029 from USD 4.34 billion in 2020.
Infusion Pump Market
https://exactitudeconsultancy.com/reports/1224/infusion-pumps-market/
The global infusion pump market is anticipated to grow from USD 9.4 billion in 2020 to USD 18.6 billion by 2029, at a CAGR of 8.1 % during the forecast period.
Surgical Navigation Systems Market
https://exactitudeconsultancy.com/reports/3052/surgical-navigation-systems-market/
The global surgical navigation systems market size is expected to grow at more than 6.3% CAGR from 2022 to 2029. It is expected to reach above USD 2,300 million by 2029 from USD 800 million in 2020.
Controlled Release Drug Delivery Market
https://exactitudeconsultancy.com/reports/3477/controlled-release-drug-delivery-market/
The global controlled release drug delivery market size is expected to grow at 7.8% CAGR from 2022 to 2029. It is expected to reach above USD 78.41 billion by 2029 from USD 39.88 billion in 2020.
Nuclear Imaging Equipment Market
https://exactitudeconsultancy.com/reports/5639/nuclear-imaging-equipment-market/
The global Nuclear Imaging Equipment Market size is USD 2.60 billion in 2020 and is expected to grow till USD 4.43 billion by 2029, at a Compounded annual growth rate (CAGR) of 6.31%.
Dental Consumables Market
https://exactitudeconsultancy.com/reports/2464/dental-consumables-market/
The global dental consumables market is expected to grow at 10.5% CAGR from 2019 to 2028. It is expected to reach above USD 64.37 billion by 2028 from USD 26.21 billion in 2019.
